FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate

BACKGROUND: FDG PET-CT is generally not suitable for diagnosing prostate cancer because of low glycolysis of the tumor cells. Neuroendocrine differentiation of the prostate cancer is often associated with early visceral metastasis and dismal prognosis, which is resulted from changed metabolic and re...

Descripción completa

Detalles Bibliográficos
Autor principal: Liu, Yiyan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440384/
https://www.ncbi.nlm.nih.gov/pubmed/18565231
http://dx.doi.org/10.1186/1477-7819-6-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440384/
https://www.ncbi.nlm.nih.gov/pubmed/18565231
http://dx.doi.org/10.1186/1477-7819-6-64

Ejemplares similares